In vivo, IL-30 overexpression in primary tumors facilitates the recruitment of prostate cancer stem-like cells (PCSLCs) to CXCL13, creating a microenvironment convenient for lymph node and blood metastasis30,31. The gene discussed is CXCL13; the disease is prostate carcinoma.